Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Netskope Q4 FY2026 Earnings Call - AI-native fast path and record ARR as company posts first positive free cash flow year
Netskope closed fiscal 2026 with a strong finish, reporting Q4 revenue of $196 million (32% YoY) and full-year revenue of $709 million (32% YoY). Ending ARR was $811 million, up 31% year-over-year, wi...
- Q4 revenue $196 million, up 32% year-over-year; full year revenue $709 million, up 32% YoY.
- Ending ARR $811 million, +31% year-over-year, with record net new ARR of $57 million in Q4 and $193 million for the full year.
- Netskope reported its first full fiscal year of positive free cash flow, $12 million for FY2026, an improvement of $163 million versus FY2025.
- +17 more takeaways
Telecom Argentina FY2025 4Q2025 Earnings Call - TMA deal boosts scale and margins, leverage kept in check
Telecom Argentina leaned into scale in 2025, folding Telefónica Móviles Argentina into consolidated results and delivering a noticeable step-up in margins and cash generation. The acquisition added me...
- Consolidated revenues exceeded $5.7 billion for fiscal 2025, up about 53% year over year in constant Argentine pesos, driven primarily by the inclusion of TMA from March to December 2025.
- Service revenues excluding TMA grew in real terms, the first annual real growth since Telecom adopted IAS 29, marking an operating inflection after two years of sequential improvement.
- Consolidated EBITDA margin expanded to over 30.3% in constant currency (31.7% nominal); excluding an increase in TMA severance run rate, consolidated margin would be above 32%.
- +15 more takeaways
Elutia, Inc. Q4 2025 Earnings Call - NXT-41x advancing to FDA with H2 2027 commercial launch planned; SimpliDerm being shopped
Elutia spent the quarter consolidating a clear strategic bet. Management submitted NXT-41, the drug-free base matrix meant to streamline regulatory review for the drug-eluting NXT-41x, and laid out co...
- Elutia submitted NXT-41, the nondrug biologic matrix, to FDA as the regulatory lead for NXT-41x, aiming to speed the pathway for the drug-eluting product.
- Management expects NXT-41 clearance in H2 2026, with NXT-41x clearance toward end of H1 2027 and a commercial launch in H2 2027, timelines described as conservative.
- NXT-41x combines rifampin and minocycline in a biologic matrix, designed for sustained local antibiotic delivery, roughly targeted to 30 days to cover the typical 17-day drain period.
- +11 more takeaways
CuriosityStream Q4 2025 Earnings Call - Licensing Poised to Eclipse Subscriptions as AI Demand Scales
CuriosityStream closed 2025 with strong top-line and cash gains, driven by an acceleration in AI and traditional licensing. Full year revenue rose 40% to $71.7 million, adjusted free cash flow jumped ...
- Full year 2025 revenue grew 40% to $71.7 million, with Q4 revenue up 36% year over year to $19.2 million.
- Adjusted free cash flow for 2025 rose 46% to $13.9 million, and Q4 adjusted free cash flow was $4.3 million, marking eight consecutive quarters of positive operating cash.
- Adjusted EBITDA turned positive, $1.1 million in Q4 and $8.2 million for the full year, compared with a loss in 2024.
- +14 more takeaways
Fossil Group Q4 2025 Earnings Call - Turnaround Delivers Margin Recovery, Positive 2026 Profit Guidance
Fossil closed 2025 with a clean, measurable turnaround: $1.0 billion in revenue, a 380 basis point gross margin expansion to 55.9%, more than $100 million of SG&A cuts, and positive adjusted operating...
- Full-year 2025 net sales: $1.0 billion.
- Full-year gross margin expanded 380 basis points to 55.9%, Q4 gross margin was 57.4% (up 350 basis points year over year).
- Adjusted operating income of $11 million for both Q4 and full year 2025, after two years of losses.
- +15 more takeaways
Digimarc Corporation Q4 2025 Earnings Call - Secure Gift Card rollouts set stage for 2026 ARR surge
Digimarc closed Q4 2025 with operational momentum and a clear pivot: move the Secure Gift Card solution from pilots into retailer rollouts and let that drive ARR growth in 2026. Management reported th...
- Secure Gift Card is management's top near-term growth lever, with the first commercial order signed and rollout plans with 8 North American retailers, including 4 of the largest.
- First Secure Gift Card commercial order represents over $500,000 in ARR, covering cards from 6 closed-loop and open-loop brands; under current subsidized pricing this equals less than 0.1% of U.S. SAM.
- Management estimates U.S. serviceable addressable market for gift cards at 3 billion to 5 billion cards annually, global SAM at 7.5 billion to 17 billion cards annually.
- +16 more takeaways
Stitch Fix Q2 FY2026 Earnings Call - AI and assortment upgrades fuel 9.4% revenue growth and margin leverage
Stitch Fix delivered another quarter of proof that its 18-month transformation is working. Q2 revenue rose 9.4% to $341.3 million, driven by larger, more flexible Fixes, a stronger assortment includin...
- Revenue beat expectations, rising 9.4% year-over-year to $341.3 million in Q2 FY2026.
- Revenue per active client reached $577, up 7.4% year-over-year, the highest RPAC reported as a public company.
- Fix Average Order Value increased 9.8% year-over-year, supported by more items per Fix and higher average unit retail, the tenth consecutive quarter of Fix AOV growth.
- +17 more takeaways
Petco Q4 2025 Earnings Call - Reach for the Sky: turning improved margins into growth across product, services, stores, and omni-channel
Petco closed fiscal 2025 by completing a heavy lift: margin expansion, inventory discipline, and opportunistic debt reduction that together materially improved cash flow and profitability. Full-year A...
- Petco delivered fiscal 2025 operating progress: Adjusted EBITDA rose 21.3% to $408 million and free cash flow increased 276% to $187 million.
- Full-year gross margin expanded 66 basis points to 38.7%, and fiscal Q4 gross margin was 38.3% (up 37 basis points), driven by pricing, mix, and SKU discipline.
- Q4 net sales were $1.52 billion, down 2.4%; comparable sales declined 1.6%, reflecting intentional cuts to unprofitable sales.
- +13 more takeaways
Exodus Q4 2025 Earnings Call - Building a Payments-First Future with Exodus Pay and W3C
Exodus used Q4 to draw a line under a decade of speculation-driven revenue and bet the company on payments infrastructure. Full-year revenue nudged up 5% to $121.6 million while trading-driven Q4 resu...
- Full-year 2025 revenue was $121.6 million, up 5% year over year; Q4 revenue was $29.5 million, down 3% sequentially and down 34% year over year versus a record Q4 2024.
- Full-year swap volume rose to $6.89 billion, a 21% increase year over year, showing platform growth despite a weaker digital asset price backdrop.
- Q4 swap volume was $1.59 billion, down 9% sequentially and down 32% year over year, tracking the market pullback in late 2025.
- +13 more takeaways
Informa TechTarget Q4 2025 Earnings Call - Margin Expansion Now, Revenue Growth Targeted for 2026 via AI and Integration
Informa TechTarget closed 2025 with flat revenue and materially better margins, saying the hard work of combining businesses and extracting synergies has begun to pay off. Full-year revenue on a combi...
- Full-year 2025 revenue was $486.8 million on a combined company basis, broadly flat versus $490.4 million in 2024.
- Adjusted EBITDA for 2025 reached $87.3 million, a 10% increase from $78.8 million in 2024, and ahead of guidance of $85 million.
- Adjusted EBITDA margin expanded to 17.9% for the year, a 180 basis point improvement versus prior year.
- +13 more takeaways